Back in the 1970s, researchers began tackling the quest for better skin treatments by searching for steroids with more targeted anti-inflammatory effects and fewer drawbacks. Halometasone entered the scene as a synthetic corticosteroid, answering a demand for better relief in dermatology. Its roots trace back to advances in halogenated steroids, where chemists carefully tweaked molecular structures. Their goal wasn’t just power, but the right kind of selectivity—reducing redness and itching while dodging the thinning skin and other headaches old-school steroids brought. Over time, the compound carved out a respected corner in the crowded world of topical skin therapies, standing alongside heavy hitters like betamethasone and clobetasol, but with its own chemical twist.
Take a walk through any dermatology ward and halometasone creams or ointments turn up on carts and prescription lists. The drug arrives in strengths usually ranging from 0.05% to 0.1%. It’s labelled for use on conditions like eczema, psoriasis, and stubborn allergic reactions. Pharmacies handle it as a prescription item, signaling the need for healthcare guidance before use; this isn’t a grab-and-go over-the-counter cream. Formulators combine halometasone with soft, fast-absorbing bases, mindful that anyone dealing with nagging rashes hopes for a cream that won’t sting or sit greasy on the skin. Some manufacturers blend it with antifungals or antibiotics for combo treatments, targeting both inflammation and secondary infections that sometimes follow persistent scratching.
Halometasone stands as a white, odorless powder in its raw form. The melting point hovers around 220 degrees Celsius—a detail that matters more in the lab than in daily use, but gives clues to its chemical stability. Structurally, it features a chlorinated and fluorinated steroid backbone, granting it enhanced activity and a sort of chemical “armor” against metabolic breakdown. Its formula, C22H27ClF2O5, reveals how scientists have borrowed from nature and layered on functionality. This fortification through halogen atoms not only improves skin penetration but helps the active part stay potent long enough to beat back inflammation without breaking down quickly.
Every box or tube of halometasone comes with specifications for concentration, preservative choice, and expiry data. Manufacturers print directions geared towards safety: thin application, limited duration, keeping the mix away from eyes and open sores. Labeling must state batch number and production date—data that regulators check for compliance and traceability. Some packages warn about possible side effects like skin atrophy, and remind users not to cover treated skin with air-tight dressings unless told by a clinician. Over the years, regulatory agencies worldwide—from Europe’s EMA to the FDA in the U.S.—have shaped these standards, aiming to protect end users from misuse and ensure the drug in the tube matches what the label promises.
The journey from raw chemicals to finished cream speaks to the complexity of pharmaceutical manufacturing. In industry, chemists build halometasone from simpler steroid starting materials, using steps that include halogenation, oxidation, and careful purification. Each step uses controlled conditions, often monitored by chromatography to confirm purity and concentration between stages. Production doesn’t end with the active ingredient; formulating it into a cream involves melting, mixing, and homogenizing, followed by sterile packaging. Any slip in temperature or contamination could ruin the batch, so staff manage details with precision, drawing on decades of experience. The outcome—a safe, consistent product—is the result of relentless attention from scientists and operators alike.
Halometasone belongs to a family of molecules forged by modifying the core steroid skeleton. Chemists start by introducing chlorine and fluorine atoms at key sites, boosting anti-inflammatory action and fine-tuning how the drug moves through skin layers. These adjustments mean halometasone outperforms earlier steroids like hydrocortisone. Sometimes researchers tweak functional groups or add protective chemical rings, trying to make new analogs that work faster or last longer. In labs around the world, scientists keep testing such variations, hoping to strike a blend of power, speed, and fewer troublesome effects. As the years pass, these explorations feed into the broader push for smarter steroid therapy—and sometimes lead to the launch of next-generation drugs.
Pharmacists and researchers know halometasone not just by its common name, but through an alphabet soup of alternatives—halomethasone, 21-chloro-6α,9-difluoro-11β,17-dihydroxy-pregna-1,4-diene-3,20-dione-17-propionate, and a range of international tradenames like Sicorten and Haloderm. Its chemical identifiers pop up in regulatory registers, research papers, and customs documents. For anyone working in international trade or healthcare, recognizing these synonyms means fewer mix-ups—especially since steroids with closely related names can behave very differently on skin.
Working with halometasone demands focus, whether in a research lab or a pharmaceutical plant. Strict ventilation rules keep powders from drifting, while personal protective equipment shields workers from accidental contact, since even trace amounts absorbed through skin may trigger side effects. Detailed training covers everything from spill cleanup to emergency washing routines. Finished products get safety data sheets, not just for staff handling them, but for professionals and patients downstream: these include warnings about allergic reactions, storage temperatures, and proper disposal. From raw chemical receiving to boxing up finished tubes, every step answers to a checklist—and regular inspections by health authorities make sure there’s no slipping up.
Halometasone creams turn up mostly in dermatology clinics, filling a need among people battling eczema, lichen planus, or stubborn dermatitis. Doctors reach for the steroid in cases resistant to milder treatments, using it for short periods to knock down inflammation fast. Occasionally, halometasone steps in for treatment plans tackling psoriasis plaques or allergic rashes on body areas where quick relief keeps patients from scratching themselves raw. Precise dosing and limited-duration use are important—misuse can thin skin or prompt other unwelcome effects. Many patients reporting improved symptoms find halometasone reliable, but clinics keep tabs during therapy, watching for warning signs of side effects or steroid overuse.
Research around halometasone keeps rolling, with teams running studies on newer combinations and advanced drug delivery. Some groups research nanoformulations or slow-release patches to make treatment both potent and gentle. Clinical trials check how halometasone stacks up against other steroids—sometimes head-to-head, sometimes in blends with antifungals or antibiotics. Universities and pharma companies dig for differences in skin penetration, inflammation markers, and patient experience. They also look for signals that might minimize risks in long-term therapy, especially for those needing repeat courses. These efforts tie directly to better outcomes and smarter prescribing, echoing through journals and treatment guidelines worldwide.
No powerful steroid escapes close study on its downsides. Scientists track what happens when too much halometasone goes on skin, especially over large areas or under tight dressings. Research has shown risks of local reactions—irritation, thinning, pigment changes—with overuse. Animal studies, plus careful long-term follow-ups in people, try to spot less obvious issues, like hormone suppression or impacts on children’s growth. Periodic reviews update safety guidelines, flagging new findings as they emerge. This vigilance matters, not only for individual patients but for shaping regulations and pharmacy practice. By making these findings widely available, the medical community aims to keep therapy both effective and as safe as possible.
The story of halometasone isn’t done. Formulators and researchers voice excitement for next-wave delivery systems, including smart hydrogels or transdermal patches. Improvements could bring fewer side effects, more targeted relief, or both—helping patients avoid tough trade-offs. In the pipeline, combination therapies with antimicrobials or next-generation anti-inflammatories may broaden its reach, giving hope in hard-to-treat cases. Rising interest in personalizing medicine—matching drug choice to genetics and skin type—could shape where halometasone fits best. Its journey shows how chemistry, hard-won clinical knowledge, and patient need converge. Each step forward depends on research, vigilance, and a dash of creative thinking.
Halometasone doesn’t ring a bell for most people until skin issues show up. This steroid, packed into prescription creams and ointments, comes into play for some of the most stubborn skin conditions. Doctors reach for it when common moisturizers or over-the-counter tubes just aren’t cutting it. Psoriasis, eczema, and relentless allergic rashes prompt specialists to look for something stronger. The red, itchy, inflamed symptoms that ruin sleep and daily comfort often push people to seek help; halometasone gives them a real shot at relief.
Every patch of eczema I’ve seen on a friend or family member brings home the same thing—these aren’t just mild annoyances. The burning and itching keep people from sleeping. Steroids like halometasone fight that intense itch and swelling. They do this by switching off signals that make the immune system overreact. Once the inflammation comes down, skin starts healing. It feels good to see kids and adults finally able to stop scratching themselves raw and get back to school or work.
Halometasone is potent. Short bursts work wonders, but using too much for too long can bring trouble. Thinner skin, stretch marks, and changing pigment often show up with careless use. In rare cases, some steroids even seep through the skin, entering the bloodstream and nudging up blood pressure or changing hormone levels. No one wants that. Dermatologists and pharmacists warn about keeping steroid use short, sticking to the doctor’s words, and never smearing it on big patches of skin unless told. Teaching families to respect those instructions makes a difference, especially with children, folks dealing with long-term conditions, or older adults whose skin bruises easily.
The tough part is handling fear. There’s a well-known story in every doctor’s office—parents or patients who saw thinning skin or read an online horror story about steroids. They get worried. Earlier in my life, I saw relatives stop using the cream too quickly, only for their symptoms to come roaring back. Education gives people clear answers. Registered health professionals explain how small amounts, used the right way, bring relief and avoid the risks. Getting that message to stick is half the battle. In my local pharmacy, keeping steroid creams behind the counter forces people to check with the pharmacist. More conversation means more trust and fewer accidents.
It’s easy to think stronger means better, but low and slow wins. Always use the thinnest layer. Hands should always get washed after rubbing in the cream. Careful timing helps, too. Short courses—often just one to two weeks—settle most flares before complications arrive. Doctors and pharmacists encourage check-ins if a spot doesn’t improve in a week. If things don’t get better, there could be an infection or a diagnosis that needs changing. Staying connected to healthcare professionals keeps patients safe. Patients who ask questions and mention past trouble with steroid creams get tailored advice. That attention means fewer setbacks and better skin results for everyone.
Anyone dealing with tough rashes or chronic flare-ups deserves reliable options. Halometasone brings fast, effective relief if used with care and honesty. Respect for expert advice, patient education, and short, targeted applications keep problems in check. Hearing personal stories, seeing real results, and sharing honest dialogue open the path to safer chronic skin care for families and healthcare teams alike.
Halometasone finds its place among corticosteroids that treat various skin conditions like eczema, psoriasis, and dermatitis. It helps calm down itchiness, redness, and swelling—issues I see all too often on family and friends, especially during allergy season or stressful weeks. When you see a doctor for a stubborn rash and they hand over a prescription for halometasone, you’re dealing with a cream that packs real punch, not a casual moisturizer from the store shelf.
Doctors recommend you use just a small amount of halometasone. That’s not just a cost-saving tip—it’s for safety. Slathering it thick doesn’t speed up healing; it just puts your skin at risk for problems like thinning or even stretch marks. It’s best to wash your hands and gently clean the affected area ahead of time. After that, a thin layer across the problem patch two times a day usually works, unless your doctor says otherwise. Many patients forget that one fingertip of cream often stretches further than you’d expect.
I’ve made the mistake of using steroid creams too close to the eyes in hopes of clearing up stubborn eczema, only to get a burning sensation and regret that decision for days. Halometasone isn’t meant for sensitive zones like the eyelids, groin, or face unless the doctor specifically directs it. Kids and older adults need special caution since their skin absorbs more of the medicine. If I ever see a family member with a rash on the face, I steer them right back to their doctor before reaching for the halometasone tube.
Using halometasone without a check-in from a medical professional is risky. Cases of folks treating fungal infections or acne with steroid creams often end up worse—not better. Corticosteroids like this work by taming an inflamed immune system in the skin, but infections like ringworm thrive under that immunosuppression. Trying it out on the wrong diagnosis costs time and can even cause scarring. I’ve had friends ask how to clear up a red, itchy patch and were surprised to find that using halometasone for more than two weeks can actually backfire, making the problem return even angrier.
Long-term use brings its own bag of troubles—think stretch marks, thinning skin, easy bruising, or even suppressed adrenal glands. Doctors keep an eye on folks at higher risk for these kinds of reactions. They suggest stopping the cream as soon as improvement appears, not pushing on as a routine skin solution. If you see strange changes like skin lightening, don’t ignore them—get that checked before using more cream.
Pharmacies carry halometasone under many brand names. Never share your tube with others, even if you trust your relative’s judgment. Dermatologists repeat one thing time and again: the right diagnosis means everything. Only use as prescribed, keep the dose low and duration short, and never substitute it for itch relief without a doctor’s explicit recommendation. If flare-ups continue or things get worse, schedule a follow-up—don’t try to double up on applications hoping for a miracle.
Sticking to medical advice and practical habits keeps strong steroid creams like halometasone working for the long haul, instead of turning today’s rash into next month’s regret.
Stepping into a pharmacy, you’ll see a variety of creams and ointments promising relief from skin flare-ups. Halometasone often gets the nod for stubborn cases. As a corticosteroid, it tackles redness and itching fast, which feels like a relief for many. Yet, not everyone talks about the bumps that come along for the ride with long-term or even routine use.
After using Halometasone for a week on a rash that wouldn’t quit, I noticed a change. The irritation eased, but the skin looked a bit thinner. That thin, almost delicate tissue worried me. I later learned that corticosteroids can break down collagen with repeated use. This makes the skin bruise or cut much easier. A 2021 review in Dermatology Research and Practice pointed out that skin atrophy pops up pretty often for people who reach for steroid creams too frequently.
Pimples aren’t only for teenagers. After using Halometasone, some folks spot new acne or even tiny pus-filled blisters — a side effect known as folliculitis. The New England Journal of Medicine published a patient image series showing these bumps sometimes crop up after just a short course. From personal experience, switching from daily use to once every few days gave my skin a breather, and problems settled down.
People rarely realize that medicines delivered through the skin still find their way deeper. A study in JAMA Dermatology revealed that potent steroids can get absorbed, especially on thin-skinned spots like the face or inner arms. Halometasone raises cortisol levels in some unlucky folks, even when used in small amounts over larger areas. That can throw your body’s own hormone balance out of whack — a risk the FDA flags on prescription leaflets. Kids process these medicines faster, so extra caution matters for them.
No one expects a cream meant to soothe skin to cause a new rash. Yet, allergic reactions do happen. Redness, burning, and intense itch may signal your body isn’t happy with halometasone. Reports to the European Medicines Agency flag reactions ranging from hives to swelling, though numbers stay relatively low. Still, for anyone with sensitive skin or a history of allergies, patch testing on a small spot can sidestep bigger trouble down the road.
Halometasone works wonders on tough skin cases, but it isn’t a fuss-free fix. Small amounts, short courses, and staying away from broken or sensitive skin mark the safest path. Regular check-ins with your dermatologist let you catch unwanted effects before things spiral. Bringing the full list of medicines you use — even over-the-counter or herbal fixes — can avoid surprise reactions. Moisturizers without scents or extra chemicals give extra support to healing skin. A healthy respect for side effects, not fear, helps everyone use Halometasone wisely and safely.
If you’ve ever spent time at a dermatologist’s office, you’ve probably seen a cream or ointment with a name like halometasone. It’s a strong corticosteroid. People get it for stubborn skin problems—like eczema and psoriasis—that just don’t quit.
Ask anyone who’s had a flare-up and they’ll tell you: relief has value. Fast. Creams like halometasone work by calming inflammation. This steroid packs a punch. Trouble is, the stuff doesn’t just single out the itchy spots. It can seep deeper, even get into the bloodstream. Over months or years, what started as a quick fix can become its own headache.
I’ve seen plenty of folks rely on these creams. Sometimes doctors run out of other options, so keeping symptoms at bay matters more than anything else. Still, the side effects that pile up can’t be ignored. Thinning skin sneaks up on you—suddenly, it bruises or tears with a brush against the door. Stretch marks around elbows and knees stick around for life. Infections, both bacterial and fungal, seem to get bold. Eyes might develop cataracts or glaucoma after regular use near the face. Children are even more at risk since their skin soaks up medicine fast and their bodies are small; growth gets affected, hormones skew.
All those worries have been measured in research. For example, one review in the journal Dermatology (2022) highlights both local and whole-body problems after long-term use. The FDA notes similar concerns, pointing out that steroid creams under tight wraps or on big areas make it easier for halometasone to get inside and cause trouble. The World Health Organization suggests using strong corticosteroids like this only for as long as the skin really needs—and under strict medical advice.
Everyday people facing flare-ups don’t want another scare tactic. Honest information matters. Dermatologists often guide patients through something called “steroid holidays”—where the cream gets swapped with gentler options, like moisturizers or non-steroid medications. Some people use potent creams just on limited spots and only for stubborn patches. I’ve watched folks keep logs about when and where they use their prescription, helping both patient and doctor stay one step ahead of side effects.
If someone feels lost in symptoms, it helps to ask questions. Is there an alternative, like topical calcineurin inhibitors for eczema, or phototherapy for psoriasis? Can lifestyle changes—less stress, better sleep, less scratching—make a dent so the medication gets used less often? Nobody deserves to feel stuck between misery and side effects. Smart medical advice and regular check-ins let patients and doctors catch trouble early, before it builds up. Education is power here.
Safe, long-term skin health doesn’t come from fear. It comes from knowing what you’re putting on your body, how often, and why. Staying in touch with your doctor and reporting changes—good or bad—can preserve the benefits of halometasone while shrinking the risks. People can reclaim control, as long as they know what to watch for and where to turn.
Caring for a child with itchy, stubborn skin troubles brings more questions than answers. I still remember standing in a pharmacy, prescription in hand, reading a label for the first time and running into names like halometasone. It’s a potent topical steroid—stronger than many creams that sit in medicine cabinets. This raises a point: parents deserve clarity about using such medicines on kids’ skin.
Halometasone treats flare-ups like eczema and stubborn rashes. It can deliver fast relief by calming swelling and itch. In children, that itch can become more than an inconvenience. Kids scratch. Sleep disappears. The whole family loses patience. It’s tempting to reach for the strongest tool in the box. But halometasone’s strength brings trade-offs, especially for bodies still growing.
Kids have thinner, more absorbent skin compared to adults. When parents apply halometasone too often or on large patches, more steroid goes into the body. Kids’ systems react faster, which makes expert oversight critical. Research published in journals like Pediatric Dermatology and the British Journal of Dermatology consistently highlight side effects, including skin thinning, stretch marks, and rare, but serious, hormonal disruptions. Nobody wants to trade a rash for another health problem.
Major dermatology groups, like the American Academy of Dermatology, flag high-potency steroids as a last resort for children. Halometasone sits on the higher end of that spectrum. Studies show that brief use in targeted areas (like behind the knees or elbows) brings relief without much trouble. Problems tend to stack up after days of use, or if parents cover the treated patches with bandages, making the medicine press deeper.
There’s also the risk of missing a bigger issue. A patch that doesn’t heal after a few days of steroid use might point to infection or something beyond standard eczema. This underlines one truth from my own experience: using a strong steroid on a child’s skin requires more than a prescription. It needs guidance, follow-up, and a doctor who wants to listen as much as diagnose.
Safer paths exist for families. A pediatrician or dermatologist can recommend milder creams, sometimes starting with non-steroid balms or lower-potency steroids. When halometasone steps in, keep use short—usually less than two weeks—and on small areas. Daily check-ins about progress, new marks, or mood swings can catch trouble before it sets in. Storing the tube in a place only adults reach also prevents curious little hands from experimenting.
Healthy skin doesn’t always come from the strongest cream. Parents who live with eczema in the house know how triggers—from cheap soaps to laundry powder—often set off trouble. Focusing on those basics, with expert support, means fewer flares and less need for heavy-duty medicine.
As medical science grows, new reports keep steering families away from old habits of rubbing on strong steroids for every rash. Halometasone can help at the worst moments, but no family should walk that path alone. The real lesson: honest conversations with a knowledgeable doctor create the conditions for safe healing. Kids get relief. Families sleep better. Everyone comes out stronger, not just the medicine.
| Names | |
| Preferred IUPAC name | (6α,11β,16α)-2-Chloro-6,9-difluoro-11,17,21-trihydroxypregna-1,4-diene-3,20-dione |
| Other names |
Halomethasone
NRP 2945 SCS 348 |
| Pronunciation | /ˌheɪ.loʊˈmɛt.əˌsoʊn/ |
| Preferred IUPAC name | (6α,11β,16α)-2-Chloro-9-fluoro-11,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione |
| Other names |
Ft 080
Halomethasone Halometasonum |
| Pronunciation | /ˌhæloʊˈmɛtəˌsoʊn/ |
| Identifiers | |
| CAS Number | 50629-82-8 |
| Beilstein Reference | 2651895 |
| ChEBI | CHEBI:31622 |
| ChEMBL | CHEMBL2104706 |
| ChemSpider | 70095 |
| DrugBank | DB16585 |
| ECHA InfoCard | 1007001 |
| EC Number | EC 3.2.1.27 |
| Gmelin Reference | Gmelin Reference: **366133** |
| KEGG | D01739 |
| MeSH | D017366 |
| PubChem CID | 25112 |
| RTECS number | UF9635000 |
| UNII | XN0Z39JZ7R |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID3020981 |
| CAS Number | 50629-82-8 |
| 3D model (JSmol) | `3D model (JSmol)` string for **Halometasone**: ``` CC1(C2CCC3(C(C2(CCC1O)C)C(=O)CO3)F)C(=O)COC(=O)CCl ``` |
| Beilstein Reference | 55716 |
| ChEBI | CHEBI:31415 |
| ChEMBL | CHEMBL1200309 |
| ChemSpider | 234052 |
| DrugBank | DB16572 |
| ECHA InfoCard | 100000023498 |
| EC Number | EC 4.2.1.62 |
| Gmelin Reference | Gmelin Reference: "1155246 |
| KEGG | D01774 |
| MeSH | D017025 |
| PubChem CID | Hier ist die Antwort als angeforderter „string“: "64788 |
| RTECS number | BV9057300 |
| UNII | 4W4EN929IX |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C22H27ClF2O5 |
| Molar mass | 532.004 g/mol |
| Appearance | White or almost white cream |
| Odor | Odorless |
| Density | D = 1.37 g/cm³ |
| Solubility in water | Practically insoluble in water |
| log P | 2.2 |
| Vapor pressure | 2.01E-13 mmHg |
| Acidity (pKa) | 12.69 |
| Basicity (pKb) | 1.97 |
| Magnetic susceptibility (χ) | -94.5e-6 cm^3/mol |
| Refractive index (nD) | 1.585 |
| Dipole moment | 2.52 D |
| Chemical formula | C22H27ClF2O5 |
| Molar mass | 532.025 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 0.997 g/cm³ |
| Solubility in water | Insoluble in water |
| log P | 2.4 |
| Vapor pressure | 4.3 x 10^-9 mmHg |
| Acidity (pKa) | 14.75 |
| Basicity (pKb) | 1.92 |
| Magnetic susceptibility (χ) | -85.5·10⁻⁶ cm³/mol |
| Dipole moment | 4.02 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 343.6 J·mol⁻¹·K⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -6933 kJ/mol |
| Pharmacology | |
| ATC code | D07AC15 |
| ATC code | D07AC14 |
| Hazards | |
| Main hazards | May cause skin irritation, allergic reactions, burning, itching, dryness, and, with prolonged use, systemic absorption leading to adrenal suppression. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | HA,Me,O,ST,ONE |
| Signal word | Danger |
| Hazard statements | H373: May cause damage to organs through prolonged or repeated exposure. |
| Precautionary statements | Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. For external use only. Avoid contact with eyes. If irritation develops, discontinue use and consult a physician. |
| NFPA 704 (fire diamond) | NFPA 704: 2-2-0 |
| Flash point | Flash point > 110°C |
| Lethal dose or concentration | LD50 (rat, oral): >5000 mg/kg |
| LD50 (median dose) | LD50 (median dose): Rat oral LD50 = 620 mg/kg |
| NIOSH | WN6483000 |
| PEL (Permissible) | 0.1 mg/m3 |
| REL (Recommended) | 0.05 mg/mL |
| Main hazards | May cause skin irritation, allergic reactions, and systemic absorption leading to adrenal suppression with prolonged use. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | GH500 |
| Signal word | Warning |
| Hazard statements | H373, H411 |
| Precautionary statements | P201, P202, P264, P280, P308+P313, P405, P501 |
| Flash point | 101.6°C |
| Lethal dose or concentration | LD50 (rat, dermal) >15 g/kg |
| LD50 (median dose) | LD50 (median dose) of Halometasone: "1310 mg/kg (rat, oral) |
| NIOSH | Not listed |
| PEL (Permissible) | Not Established |
| REL (Recommended) | 0.05 mg/g |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Betamethasone
Clobetasol propionate Dexamethasone Fluocinolone acetonide Mometasone furoate |
| Related compounds |
Betamethasone
Dexamethasone Fluocinolone acetonide Fluocortolone Prednisolone |
Providing high-quality chemical products and logistics solutions for global trade partners.
